Dr Nick Maisey
MB BS FRCP MD
Title: Consultant Medical Oncologist
Specialty 1: Oncology - Medical
Specialty 1 Specialisation: GI malignancies
Clinical Interests: The management and treatment of lymphoma and gastrointestinal malignancies
Pen Picture: Dr Nick Maisey qualified in 1993 from Guys and St Thomas' Hospital, and was awarded MRCP in 1997. He completed his specialist training in medical oncology at the Royal Marsden Hospital. During his specialist training he was successful in receiving a grant from the National Cancer Institute to perform research at the Institute of Cancer Research in London. In 2002 he was awarded an MD thesis for his work on early response markers in lymphoma. He has published several peer reviewed papers and presented at a number of national and international meetings. He is a consultant in Medical oncology at Guys and St Thomas' NHS trust where he is currently the service improvement lead for lymphoma. His clinical interests are lymphoma and gastro-intestinal cancer.
Languages Spoken: English
Regular Cromwell Clinics: Yes
Telephone Number: 020 7460 5626/7
Clinic days:
Mon
:
Tue
:
Wed
: ad hoc
Thurs
:
Fri
:
Sat
:
Year Qualified: 1993
Memberships: RCP,BMA, ACP, ASCO
NHS Hospital: Guy's & St Thomas' NHS Trust
Additional Posts:
Research Interests: The use of novel agents in lymphoma and gastro-intestinal malignancies
Published Papers: • N. R. Maisey, M. E. Hill, A. Webb, D. Cunningham, G. D. Flux, A. Padhani, R. J. Ott, A. Norman, L. Bishop. Are FDG-PET And MRI Useful In The Prediction Of Relapse In Lymphoma Residual Masses?
European Journal of Cancer, 2000; 36(2): 200-6
• N. R. Maisey, A. Webb, G. D. Flux, A. Padhani, D. C. Cunningham, R. J. Ott, A. Norman. FDG - PET In The Prediction Of Survival Of Patients With Cancer Of The Pancreas - A Pilot Study. British Journal of Cancer, 2000; 83(3): 287-93
• Nick Maisey, Ian Chau, David Cunningham, Andrew Norman, Matt Seymour, Tamas Hickish, Tim Iveson, Mary O'Brien, Niall Tebbutt, Angela Harrington, Mark Hill. A Multi-centre Randomized Phase III Trial comparing Protracted Venous Infusion (PVI) 5-Fluorouracil (5FU) with PVI 5FU plus Mitomycin-C (MMC) in Inoperable Pancreatic Cancer. J Clin Oncol. 2002 Jul 15;20(14):3130-6.
• N. R. Maisey, A. Norman, M. Watson, M. J. Allen, M. E. Hill and D. Cunningham. Baseline quality of life predicts survival in patients with advanced colorectal cancer. Eur J Cancer. 2002 Jul;38(10):1351-7.
• N. Maisey, A. Norman, Y. Prior and D. Cunningham. Chemotherapy for Primary Gastric Lymphoma: Does In-patient Observation Prevent Complications? Clinical Oncology 2004; 16 (1): 48-52